Clinical Trial Update: An Observational Study to Evaluate the Efficacy of Biweekly Romiplostim in Adult Patients With ITP [Phase 2]

View source ↗

Summary

A Phase 2 observational study evaluating the efficacy of biweekly romiplostim in adult patients with immune thrombocytopenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Nplate (romiplostim)

Snippet

Sponsor: Samsung Medical Center | Conditions: Immune Thrombocytopenia | Phase 2 | Status: UNKNOWN